Not registered yet? Get a free account.
Sign UpYou're about to leave our website and go to an external link. Are you sure?
This company is a manufacturer of pharmaceutical products covering several therapeutic categories such as analgesics / antipyretics, haematinics, multivitamin preparations
Unique Pharmaceutical Laboratories Limited, is an unlisted public company incorporated on 11 April, 1972. It is classified as a public limited company and is located in , Maharashtra. It's authorized share capital is INR 7.00 cr and the total paid-up capital is INR 7.46 lac.
Read more
** All rupee values in INR lacs. Based on March 2024 numbers.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
* INR 349 for 20+ credits purchase
1 credit = one company dashboard
| State | Type | Address |
|---|
| Designation | Name | DIN/PAN | Tenure |
|---|---|---|---|
| Director | Bharat Pravinchandra Mehta
Shareholder
|
00035444 | 45 years |
| Director | Jay Bharat Mehta
Shareholder
|
00043079 | 5 years |
| Director | Kushal Madhusudan Dalal
Shareholder
|
01286783 | 5 years |
| Additional Director | Shilpi Jay Mehta | 01674052 | 0 years |
| Additional Director | Pallavi Bharat Mehta | 00043212 | 0 years |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Networth | |||||
| Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Financials upto March 2024 available in Tofler Pro
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
As per information available, the company has no registered charges.
| Name | Status | Paid up Capital | Common Directors | Address |
|---|---|---|---|---|
| JYOTINDRA MODY HOLDINGS PRIVATE LIMITED |
Amalgamated
|
1.0 L | 3 | Maharashtra |
| ANSUYA MODY SECURITIES PRIVATE LIMITED |
Amalgamated
|
1.0 L | 3 | Maharashtra |
| NAMPLAS CHEMICALS PVT LTD |
Active
|
4.3 L | 3 | Maharashtra |
| ANSUYA MODY ENTERPRISES PRIVATE LIMITED |
Converted to LLP and Dissolved
|
10.0 L | 3 | Maharashtra |
| J. B. MODY ENTERPRISES PRIVATE LIMITED |
Converted to LLP and Dissolved
|
10.0 L | 3 | Maharashtra |
| J. B. MODY ENTERPRISES LLP |
Active
|
10.0 L | 2 | Maharashtra |
| JYOTINDRA MODY VENTURES LLP |
Active
|
10.4 Cr | 2 | Maharashtra |
| ANSUYA MODY ENTERPRISES LLP |
Active
|
10.0 L | 2 | Maharashtra |
| UNIQUE PHARMACEUTICAL LABORATORIES LIMITED |
Active
|
7.5 L | 3 | Maharashtra |
| IFIUNIK ENTERPRISES LLP |
Active
|
6.0 L | 1 | Maharashtra |
| SILVERSEAS ENTERPRISES LLP |
Active
|
1.0 L | 1 | Maharashtra |
| LEADDER TEAM LLP |
Active
|
1.0 L | 1 | Maharashtra |
| MAJORTREND CAPITAL IFSC PRIVATE LIMITED |
Active
|
1.0 Cr | 1 | Gujarat |
| VAJRA HOLDINGS PRIVATE LIMITED |
Active
|
1.0 L | 1 | Maharashtra |
| CONSENTARK DIGITAL SERVICES PRIVATE LIMITED |
Active
|
1.5 L | 1 | Maharashtra |
| MAJORTREND CAPITAL PRIVATE LIMITED |
Active
|
4.2 Cr | 1 | Maharashtra |
| AROMATHERAPY INTERNATIONAL LIMITED |
Active
|
2.3 Cr | 1 | Maharashtra |
Read more
The incorporation date of UNIQUE PHARMACEUTICAL LABORATORIES LIMITED is 11 April, 1972
The authorized share capital of UNIQUE PHARMACEUTICAL LABORATORIES LIMITED is INR ₹ 7.0 Cr.
The paid-up capital of UNIQUE PHARMACEUTICAL LABORATORIES LIMITED is INR ₹ 7.5 L.
The registered address of UNIQUE PHARMACEUTICAL LABORATORIES LIMITED is Office No 105, 10th Floor, Maker Chambers VI, 220 Jamnalal Bajaj Marg, Nariman Point, Nariman Point, Mumbai, Mumbai, Maharashtra, India, 400021 - 400021
The CIN number of UNIQUE PHARMACEUTICAL LABORATORIES LIMITED is U47722MH1972PLC015744.